| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Xin Wu | Q88942634 |
| P2093 | author name string | Yanyan Zhao | |
| Yanshi Wang | |||
| Lufang Wang | |||
| P2860 | cites work | [Expression of galectin-7 and S100A9 and development of cervical squamous carcinoma] | Q86046219 |
| Different angioregulatory activity of monovalent galectin-9 isoforms | Q87944506 | ||
| A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans | Q24308236 | ||
| A model for p53-induced apoptosis | Q24313374 | ||
| Galectin-9 induces maturation of human monocyte-derived dendritic cells | Q24317167 | ||
| Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors | Q24337334 | ||
| Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes | Q24670155 | ||
| Galectins in hematological malignancies--role, functions and potential therapeutic targets | Q26768180 | ||
| Targeting the apoptosis pathway in hematologic malignancies | Q27024422 | ||
| Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance | Q28214490 | ||
| Role of galectin-8 as a modulator of cell adhesion and cell growth | Q28242002 | ||
| Galectins. Structure and function of a large family of animal lectins | Q28246794 | ||
| Expression and functions of galectin-7 in ovarian cancer. | Q30594259 | ||
| Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction | Q30847683 | ||
| VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis | Q31121321 | ||
| Galectins structure and function--a synopsis. | Q31974744 | ||
| Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial | Q33383385 | ||
| Galectins and gliomas | Q33588438 | ||
| Dynamics of galectin-3 in the nucleus and cytoplasm | Q33625906 | ||
| God must love galectins; he made so many of them | Q33751857 | ||
| Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer | Q34031748 | ||
| Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). | Q34037992 | ||
| Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response | Q34096563 | ||
| Galectin-3 binding protein promotes cell motility in colon cancer by stimulating the shedding of protein tyrosine phosphatase kappa by proprotein convertase 5. | Q34151008 | ||
| Asian society of gynecologic oncology workshop 2010 | Q34167035 | ||
| Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells | Q34215810 | ||
| Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells | Q34247078 | ||
| Galectins as modulators of tumour progression | Q34381235 | ||
| Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells. | Q34491204 | ||
| T-cell growth, cell surface organization, and the galectin-glycoprotein lattice | Q34691040 | ||
| Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells | Q34749287 | ||
| Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis | Q35085674 | ||
| Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. | Q35161285 | ||
| Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival. | Q53319777 | ||
| Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. | Q53463132 | ||
| Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. | Q53624752 | ||
| Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. | Q54657364 | ||
| Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. | Q55285607 | ||
| Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase | Q57372072 | ||
| A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment | Q57617796 | ||
| Vascular Normalization by Loss of Siah2 Results in Increased Chemotherapeutic Efficacy | Q59262791 | ||
| Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties | Q63413190 | ||
| Immunohistochemical detection of galectin-3 in canine gastric carcinomas | Q73549175 | ||
| Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer | Q73644483 | ||
| Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family | Q73931768 | ||
| Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands | Q74232932 | ||
| The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin | Q78835035 | ||
| A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128 | Q79329253 | ||
| Increased expression of galectin-1 during the progression of cervical neoplasia | Q79440689 | ||
| Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay | Q80020827 | ||
| Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma | Q80672570 | ||
| Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices | Q81522507 | ||
| Decreased galectin-3 expression during the progression of cervical neoplasia | Q82045215 | ||
| Galectin-3 in urine of cancer patients: stage and tissue specificity | Q82213466 | ||
| Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients | Q83015114 | ||
| Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. | Q51103369 | ||
| Synthesis and in vitro evaluation of thermosensitive hydrogel scaffolds based on (PNIPAAm-PCL-PEG-PCL-PNIPAAm)/Gelatin and (PCL-PEG-PCL)/Gelatin for use in cartilage tissue engineering. | Q51737357 | ||
| Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment. | Q52664052 | ||
| Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix. | Q53101308 | ||
| Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras-Raf-Erk1/2 pathway. | Q53143098 | ||
| Galectin-1: a link between tumor hypoxia and tumor immune privilege | Q40362866 | ||
| A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression | Q40409006 | ||
| Suppression of tumor growth by galectin-7 gene transfer | Q40525075 | ||
| Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity | Q40543716 | ||
| Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. | Q40554460 | ||
| Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype | Q40656542 | ||
| Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. | Q40677265 | ||
| Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction | Q40848658 | ||
| Concentrations of galectin-3 in the sera of normal controls and cancer patients | Q40884459 | ||
| Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. | Q40978390 | ||
| The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells. | Q41348806 | ||
| Galectin-1 is a diagnostic marker involved in thyroid cancer progression | Q41470048 | ||
| BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling | Q41489850 | ||
| Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases | Q41494591 | ||
| FOXM1 facilitates gastric cancer cell migration and invasion by inducing Cathepsin D. | Q42366607 | ||
| Galectins in regulation of apoptosis | Q44175337 | ||
| Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix | Q44893677 | ||
| Galectin-1 induced activation of the mitochondrial apoptotic pathway: evidence for a connection between death-receptor and mitochondrial pathways in human Jurkat T lymphocytes | Q45722433 | ||
| Apoptosis of T cells mediated by galectin-1. | Q46356564 | ||
| Interaction of galectin-9 with lipid rafts induces osteoblast proliferation through the c-Src/ERK signaling pathway | Q46972880 | ||
| Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting | Q47995916 | ||
| Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis | Q48119227 | ||
| Gel-Based Gelatin Zymography to Examine Matrix Metalloproteinase Activity in Cell Culture | Q50109716 | ||
| Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells | Q35314084 | ||
| Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival | Q35392528 | ||
| Introduction to galectins | Q35646606 | ||
| Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer | Q35661292 | ||
| A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells | Q35723822 | ||
| Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells. | Q35756960 | ||
| Galectin-3 induces endothelial cell morphogenesis and angiogenesis | Q35809815 | ||
| Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. | Q35945071 | ||
| Galectin-1 as a potential cancer target | Q36078029 | ||
| Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment | Q36112218 | ||
| Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma | Q36340825 | ||
| The natural history of cervical HPV infection: unresolved issues | Q36691070 | ||
| Tumor-endothelial cell interactions: therapeutic potential | Q36820399 | ||
| Galectins in the tumor endothelium: opportunities for combined cancer therapy | Q36860244 | ||
| Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma | Q37703390 | ||
| Single Nucleotide Polymorphisms of DNA Repair Genes as Predictors of Radioresponse | Q37787399 | ||
| The role of galectins in colorectal cancer progression | Q37869015 | ||
| The sweet and bitter sides of galectins in melanoma progression | Q38016538 | ||
| Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. | Q38019412 | ||
| Vascular galectins: regulators of tumor progression and targets for cancer therapy. | Q38128665 | ||
| Apoptosis and molecular targeting therapy in cancer | Q38228349 | ||
| Galectins in tumor angiogenesis | Q38269050 | ||
| Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration | Q38359998 | ||
| Mitochondrial apoptosis: killing cancer using the enemy within. | Q38367962 | ||
| Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering | Q38777463 | ||
| Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein | Q39013546 | ||
| Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer. | Q39242392 | ||
| Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer. | Q39287298 | ||
| Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence | Q39367756 | ||
| Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells | Q39625206 | ||
| Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells | Q39696500 | ||
| Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways | Q39732580 | ||
| Induction of matrix metalloproteinase-9 by galectin-7 through p38 MAPK signaling in HeLa human cervical epithelial adenocarcinoma cells | Q39779939 | ||
| Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine. | Q40084369 | ||
| Galectin-1 expression in human glioma cells: modulation by ionizing radiation and effects on tumor cell proliferation and migration | Q40111279 | ||
| Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death | Q40333858 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | uterine cervix neoplasm | Q56014502 |
| Galectin, carbohydrate recognition domain, protein family | Q83138026 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 2175927 | |
| P577 | publication date | 2018-05-08 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | The Role of Galectins in Cervical Cancer Biology and Progression | |
| P478 | volume | 2018 |
| Q64901950 | Cervical Cancer Cells Express Markers Associated with Immunosurveillance. |
| Q89666780 | Effects of Galectin-1 on Biological Behavior in Cervical Cancer |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q99726272 | HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer |
| Q89587291 | Neuropilin: Handyman and Power Broker in the Tumor Microenvironment |
| Q64275592 | Neuropilins in the Context of Tumor Vasculature |
Search more.